Cybin Inc. Releases Financial Highlights and Provides Business Update
Cybin Inc. Releases Financial Highlights and Provides Business Update Successful bought deal offering brings total capital raised to-date to approximately $90 million — — Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines – — Adelia Therapeutics acquisition expands scientific team, IP portfolio and diversifies development pipeline — — Partnership with Kernel provides access to neuroimaging … — Successful bought deal offering brings total capital raised to-date to approximately $90 million — ...